1-(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine,
TAK 438,
TAK-438,
TAK438,
Vonoprazan,
TAK-438,
Vonoprazan Fumarate,
1260141-27-2,
881681-01-2,
TAK438,
Vonoprazan fumurate,
TAK 438,
UNII-4QW3X4AMLB,
1-(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine fumarate,
Vonoprazan Fumarate (TAK-438),
4QW3X4AMLB,
5-(2-Fluorophenyl)-N-methyl-1-(3-pyridinylsulfonyl)-1H-pyrrole-3-methanamine (2E)-2-butenedioate,
1H-Pyrrole-3-methanamine, 5-(2-fluorophenyl)-N-methyl-1-(3-pyridinylsulfonyl)-, 2-butenedioate (1:1),
Vonoprazan monofumurate,
1-[5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine fumarate,
Takecab (TN),
Tube601,
(E)-but-2-enedioic acid;1-[5-(2-fluorophenyl)-1-pyridin-3-ylsulfonylpyrrol-3-yl]-N-methylmethanamine,
Vonoprazan fumarate (JAN),
SCHEMBL194394,
SCHEMBL194396,
CHEMBL2064032,
EX-A097,
ROGSHYHKHPCCJW-WLHGVMLRSA-N,
BCP05635,
MFCD18633280,
s8016,
AKOS027251052,
ACN-031560,
CS-0746,
SB16720,
1-(5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine monofumarate,
1H-pyrrole-3-methanamine, 5-(2-fluorophenyl)-N-methyl-1-(3-pyridinylsulfonyl)-, (2E)-2-butenedioate (1:1),
AC-29287,
AC-29309,
BC600509,
DS-12234,
HY-15295,
SW220126-1,
D10466,
W-5774,
J-524312,
Vonoprazan,
D02CPP,
1260141-27-2 (fumarate),
A2308,
A11239,
1-(5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine,
881681-00-1,